Modeling & Simulation Cases
PopPK/PD Model to Support Phase II Waiver
Different from the conventional Phase I→II→III→NDA development route, population PK/PD analysis built on existing clinical data can be submitted to waive Phase II trials and directly advance to Phase III studies.
